The structure of apo protein-tyrosine phosphatase 1B C215S mutant: More than just an S → O change

por Scapin, Giovanna, Patel, Sangita, Patel, Vira, Kennedy, Brian, Asante-Appiah, Ernest
Publicado em 2001

Determinants of use of supervised delivery care under Ghana’s fee exemption policy for maternal healthcare: the case of the Central Region

por Asante-Sarpong, Henrietta, Owusu, Adobea Yaa, Saravanan, Sheela, Appiah, Ernest, Abu, Mumuni
Publicado no BMC Pregnancy Childbirth (2016)

Pregnancy in non-palliated functionally single ventricle: challenges of management in resource-poor settings

por Delsol-Gyan, Desrie, Aniteye, Ernest, Oppong, Samuel, Ofosu-Appiah, Ernest, Edwin, Frank
Publicado no Pan Afr Med J (2020)

The changing epidemiology of esophageal cancer in sub-Saharan Africa – the case of Ghana

por Tettey, Mark, Edwin, Frank, Aniteye, Ernest, Sereboe, Lawrence, Tamatey, Martin, Ofosu-Appiah, Ernest, Adzamli, Innocent
Publicado em 2012

Colon bypass with a colon-flap augmentation pharyngoesophagoplasty

por Tettey, Mark, Edwin, Frank, Aniteye, Ernest, Tamatey, Martin, Entsua-Mensah, Ekow, Offosu-Appiah, Ernest, Adzamli, Innocent
Publicado no Pan Afr Med J (2015)

Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a

por Guo, Zhuyan, Black, Stuart, Hu, Yuan, McMonagle, Patricia, Ingravallo, Paul, Chase, Robert, Curry, Stephanie, Asante-Appiah, Ernest
Publicado no J Biol Chem (2017)

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

por Asante-Appiah, Ernest, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Chase, Robert, Nickle, David, Qiu, Ping, Howe, Anita, Lahser, Frederick C.
Publicado no Antimicrob Agents Chemother (2017)

Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2

por Asante-Appiah, Ernest, Ingravallo, Paul, McMonagle, Patricia, Bystol, Karin, Xia, Ellen, Curry, Stephanie, Qiu, Ping, Black, Stuart, Chase, Robert, Liu, Rong, Lahser, Fred
Publicado no Antimicrob Agents Chemother (2019)

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development

por Martin, Elizabeth Anne, Lai, Ming-Tain, Ngo, Winnie, Feng, Meizhen, Graham, Donald, Hazuda, Daria J., Kumar, Sushma, Hwang, Carey, Sklar, Peter, Asante-Appiah, Ernest
Publicado no J Acquir Immune Defic Syndr (2020)

Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors

por McGivern, David R., Masaki, Takahiro, Williford, Sara, Ingravallo, Paul, Feng, Zongdi, Lahser, Frederick, Asante-Appiah, Ernest, Neddermann, Petra, Francesco, Raffaele De, Howe, Anita Y., Lemon, Stanley M.
Publicado em 2014

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV G...

por Lahser, Frederick C., Bystol, Karin, Curry, Stephanie, McMonagle, Patricia, Xia, Ellen, Ingravallo, Paul, Chase, Robert, Liu, Rong, Black, Todd, Hazuda, Daria, Howe, Anita Y. M., Asante-Appiah, Ernest
Publicado no Antimicrob Agents Chemother (2016)

Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus

por Zhou, Shuntai, Williford, Sara E., McGivern, David R., Burch, Christina L., Hu, Fengyu, Benzine, Tiffany, Ingravallo, Paul, Asante-Appiah, Ernest, Howe, Anita Y.M., Swanstrom, Ronald, Lemon, Stanley M.
Publicado no Antiviral Res (2018)

In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A

por Asante-Appiah, Ernest, Liu, Rong, Curry, Stephanie, McMonagle, Patricia, Agrawal, Sony, Carr, Donna, Rokosz, Laura, Lahser, Frederick, Bystol, Karin, Chase, Robert, Black, Stuart, Ferrari, Eric, Ingravallo, Paul, Tong, Ling, Yu, Wensheng, Kozlowski, Joseph
Publicado no Antimicrob Agents Chemother (2018)

In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

por Lai, Ming-Tain, Feng, Meizhen, Falgueyret, Jean-Pierre, Tawa, Paul, Witmer, Marc, DiStefano, Daniel, Li, Yuan, Burch, Jason, Sachs, Nancy, Lu, Meiqing, Cauchon, Elizabeth, Campeau, Louis-Charles, Grobler, Jay, Yan, Youwei, Ducharme, Yves, Côté, Bernard, Asante-Appiah, Ernest, Hazuda, Daria J., Miller, Michael D.
Publicado em 2014

Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers

por Wang, I-Ming, Zhang, Bin, Yang, Xia, Zhu, Jun, Stepaniants, Serguei, Zhang, Chunsheng, Meng, Qingying, Peters, Mette, He, Yudong, Ni, Chester, Slipetz, Deborah, Crackower, Michael A, Houshyar, Hani, Tan, Christopher M, Asante-Appiah, Ernest, O'Neill, Gary, Jane Luo, Mingjuan, Thieringer, Rolf, Yuan, Jeffrey, Chiu, Chi-Sung, Yee Lum, Pek, Lamb, John, Boie, Yves, Wilkinson, Hilary A, Schadt, Eric E, Dai, Hongyue, Roberts, Christopher
Publicado em 2012

Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial

por Wei, Lai, Jia, Ji Dong, Duan, Zhong Ping, Wang, Fu Sheng, Niu, Jun Qi, Xie, Wen, Huang, Wen Xiang, Zhang, Ming Xiang, Huang, Yan, Wang, Mao Rong, Wu, Shan Ming, Zhao, Ying Ren, Jia, Zhan Sheng, Zhao, Xu Min, Mu, Sheng Mei, Liang, Li Wen, Wang, Zaiqi, Puenpatom, Amy, Hwang, Peggy, Robertson, Michael N., Ingravallo, Paul, Asante‐Appiah, Ernest, Wei, Bo, Evans, Barbara, Hanna, George J., Talwani, Rohit
Publicado no JGH Open (2020)